You are here

vision loss

Annexon reports topline results from Phase II trial of geographic atrophy therapy

Annexon reports topline results from Phase II trial of geographic atrophy therapy

Clinical Trials Arena

clinical trials

geographic atrophy

Flag link:

Belite Bio hits go on IPO to fund late-phase vision loss clinical trials

Belite Bio hits go on IPO to fund late-phase vision loss clinical trials

Fierce Biotech

clinical trials

Flag link:

Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain

Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain

Fierce Biotech

Editas Medicine

Flag link:

Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout

Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout

Fierce Biotech

Flag link:

ReNeuron shares clinical data on stem cell vision loss therapy

ReNeuron shares clinical data on stem cell vision loss therapy

Fierce Biotech

Retinitis pigmentosa

Flag link:

Roche’s Lucentis Works To Treat Vision Loss From Diabetes

Roche’s Lucentis Works To Treat Vision Loss From Diabetes

Bloomberg

diabetic macular edema

Flag link: